FY26 ALSRP Clinical Outcomes and Biomarkers Award: develop and validate ALS biomarkers and trial outcomes
The FY26 Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) funds projects that develop or validate biomarkers and clinical outcome measures to strengthen ALS clinical trials. Applicants may target specific therapies, ALS subtypes, or particular genetic mutations, using approaches such as patient/clinician-reported outcomes, performance measure…
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in amyotrophic lateral sclerosis (AL…
Funding Source
Awards & funding
Dates
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers